IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia-Reference-Cited by-同舟云学术

IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia

Published:2017-09 Issue:3 Volume:152 Page:478-485
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Padmanabhan Anand,Jones Curtis G.,Pechauer Shannon M.,Curtis Brian R.,Bougie Daniel W.,Irani Mehraboon S.,Bryant Barbara J.,Alperin Jack B.,Deloughery Thomas G.,Mulvey Kevin P.,Dhakal Binod,Wen Renren,Wang Demin,Aster Richard H.

Funder

Indiana Clinical and Translational Sciences Institute

National Institutes of Health

American Heart Association

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference40 articles.

1. Clinical practice. Heparin-induced thrombocytopenia;Greinacher;N Engl J Med,2015

2. Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder;Warkentin;Blood,2014

3. Delayed-onset heparin-induced thrombocytopenia;Rice;Ann Intern Med,2002

4. Delayed-onset heparin-induced thrombocytopenia and thrombosis;Warkentin;Ann Intern Med,2001

5. Agents for the treatment of heparin-induced thrombocytopenia;Warkentin;Hematol Oncol Clin North Am,2010

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology;Journal of Thrombosis and Haemostasis;2024-06

2. How We Interpret Thrombosis with Thrombocytopenia Syndrome?;International Journal of Molecular Sciences;2024-05-01

3. High-Dose Immunoglobulin Therapy for Multiple Thromboembolism in Persisting Heparin-Induced Thrombocytopenia;Cureus;2024-03-07

4. Therapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT);Expert Opinion on Pharmacotherapy;2024-02-11

5. Anti-PF4 antibodies and their relationship with COVID infection;Hematology, Transfusion and Cell Therapy;2024-02